Similar to opioids and intoxicating hemp-derived THC products, a well-funded and growing kratom industry with lobbying power overstates the safety of kratom, downplays its risks, and resists
June 15, 2026
The rise of kratom, and especially its potent synthetic derivative 7-hydroxymitragynine (7-OH), feels dangerously familiar. Kratom is a psychoactive substance marketed as natural and medicinal, inadequately regulated, and defended by an industry that resists meaningful oversight
Comments